Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cyclacel Pharmaceuticals Company Profile (NASDAQ:CYCC)

Consensus Ratings for Cyclacel Pharmaceuticals (NASDAQ:CYCC) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/10/2013Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/2/2013JMP SecuritiesInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)